Vicore Pharma Holding

9,98 SEK

-0,40%

Mindre end 1K følgere

VICO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vicore Pharma Holding

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)14,3030,6513,5417,4213,808,4511,30
Aktier44,362,173,884,1114,8234,6281,5
Markedsværdi633,51.903,2998,91.465,11.584,21.982,23.181,2
Enterprise value446,11.584,6627,71.203,31.101,5826,2-
EV/S-----7,6-
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B1,975,372,615,073,481,762,90
P/S-----18,1833,4
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio94,3 %87,2 %85,0 %85,4 %91,8 %93,9 %89,8 %
Gearing ratio0,1 %0,0 %0,1 %----